
About company
Serascience Limited is a specialist cancer diagnostic company established in April 2011 to develop medical devices for the diagnosis and management of patients with myeloma and related disorders, collectively known as B-cell dyscrasias. Our innovative products will improve patient management through better diagnostic and prognostic assessment. Serascience supply a broad range of class and subclass specific anti immunoglobulin antibodies, for research use. We offer unique, highly specific, quality antibodies at a competitive price. Our catalogue includes monoclonal antibodies for all immunoglobulins classes, and a number of subclasses, as well as antibodies to the heavy and light chains of immunoglobulins. These antibodies can be used for an array of applications and assays, such as WB (Western blots), ELISAs (Enzyme-linked immunosorbent assays), IP (Immuneprecipitation), IHC (Immunohistochemistry), ICC (Immunocytochemistry), and flow cytometry.